FTD Respiratory 21 PLUS
EINLEITUNG
Upgrade your FTD Respiratory 21: FTD Respiratory 21 PLUS with a sixth multiplex detecting Chlamydia pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae B and Staphylococcus aureus.
TESTPRINZIP UND -DURCHFüHRUNG
- Extraction of total nucleic acid from respiratory samples (throat/nasal swabs, bronchoalveolar lavage, sputum) of human origin. In some cases other sample types may be tested including post mortem material such as heart and lung.
- High reliability: internal control (IC), which is introduced into the lysis buffer at the extraction stage of EACH specimen
- High safety: includes positive and negative controls for all pathogens
- Positive control pool: ONE positive pool for all pathogens to keep enzyme costs low
- Amplification and simultaneous detection of up to four pathogens in one tube
PACKUNGSINHALT
- 5-6 Optimized primer and probe mixes
- Positive pool
- Negative control
- Internal control
TECHNISCHE VORAUSSETZUNGEN
- The test is available for use with the ABI 7500, Rotor-Gene 6000, Bio-Rad CFX96 and the LightCycler480.
- This assay has been fully validated on an ABI7500 with the AgPath-ID™ One-Step RT-PCR Kit (Ambion, cat # AM1005).
HANDELSFORM
| Artikelnummer 800007 | FTD Respiratory 21 PLUS 24 (24 Patienten) |
| Artikelnummer 800008 | FTD Respiratory 21 PLUS 48 (48 Patientemn) |
| Artikelnummer 800009 | FTD Respiratory 21 PLUS 96 (96 Patienten) |

